Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-08-30
2005-08-30
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000
Reexamination Certificate
active
06936587
ABSTRACT:
A peptide compound having the sequence Lys-Pro-Ser-Ser-Pro-Pro-Glu-Glu [SEQ ID NO:2] or a substitution variant, addition variant or other chemical derivative thereof inhibits cell invasion, endothelial tube formation or angiogenesis in vitro. A number of substitution variants and addition variants of this peptide, preferably capped at the N- and C-termini, as well as peptidomimetic derivatives, are useful for treating diseases and conditions mediated by undesired and uncontrolled cell invasion and/or angiogenesis. Pharmaceutical compositions comprising the above peptides and derivatives are administered to subjects in need of such treatment in a dosage sufficient to inhibit invasion and/or angiogenesis. The disclosed compositions and methods are particularly useful for suppressing the growth and metastasis of tumors.
REFERENCES:
patent: 5416006 (1995-05-01), Blasi et al.
patent: 6509445 (2003-01-01), Kobayashi et al.
Jones Terence R.
Mazar Andrew P.
Angstrom Pharmaceuticals, Inc.
McDermott Will & Emery LLP
Tate Christopher R.
LandOfFree
Anti-invasive and anti-angiogenic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-invasive and anti-angiogenic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-invasive and anti-angiogenic compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3507390